FDA staff: J&J diabetes drug may pose heart risk

depositphotos_1085461-Vitamin-E-pills

Federal drug reviewers think Johnson & Johnson’s experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.

Read more

Posted in Drugs